@JosephMerolaMD
www.medpagetoday.com Are Clinicians Too Cautious With Targeted Therapies for Psoriatic Arthritis? Study suggests patients can safely receive multiple targeted drugs, but hardly ever do 
karger.com Treatment of Plaque Psoriasis with Guselkumab Reduces Systemic Inflammatory Burden as Measured by... Abstract. Introduction: Psoriasis is associated with an increased risk of cardiovascular disease (CVD). Previous studies have found that treatment with tumour necrosis factor or interleukin (IL)-17... 
pubmed.ncbi.nlm.nih.gov Cutaneous lupus matters: Independent and additive quality-of-life burden shown by 2022 WLFGI Survey... Cutaneous lupus matters: Independent and additive quality-of-life burden shown by 2022 WLFGI Survey 
pubmed.ncbi.nlm.nih.gov The association between obesity and efficacy of psoriasis therapies: An expert consensus panel -... Psoriasis and obesity have a strong association. Obesity decreases efficacy of biologics and may decrease efficacy and potentiate side effects of conventional therapies. It also impacts drug surviv... 